A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...

The business produces a ‘marriage of software and science’ with a ‘professor in the box’ that offers the researcher hints. Single molecule detection is the ultimate level of sensitivity.

TruSpine Technologies PLC - London Gatwick Airport-based medical device company - Continues to be in a pre-revenue development phase and remains loss-making at this stage. Pretax loss widens to GBP760 ...

A year after his Nobel Prize win, David Baker highlights AI in protein design at Seattle's latest fundraiser to support STEM PhD students.

In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights ...